BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
You can track the start of spring and the phases of the moon—or you can turn to a formula by mathematician Carl Friedrich ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results